|

Pemetrexed + Cisplatin /Carboplatin Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2/3: 1

Top Sponsors

  • Eikon Therapeutics1

Indications

  • Non Small Cell Lung Cancer (Squamous or Non Squamous)1
  • Stage 4 NSCLC1
  • Lung Cancer1
  • Cancer1

Mineola, New York1 trial

A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.

NYU Langone Hospital Long Island

Phase 2/3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.